<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36325804</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1098-4275</ISSN><JournalIssue CitedMedium="Internet"><Volume>150</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Pediatrics</Title><ISOAbbreviation>Pediatrics</ISOAbbreviation></Journal><ArticleTitle>A Toddler With New Seizures, Progressive White Matter Lesions, and Multifocal Microhemorrhages.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2022057652</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1542/peds.2022-057652</ELocationID><Abstract><AbstractText>A 16-month-old, previously healthy male is hospitalized for new onset seizures. Initial investigation is significant for enterovirus/rhinovirus respiratory infection, abnormal T2 signal predominantly in the white matter and scattered microhemorrhages on brain MRI, transaminitis, and thrombocytopenia. His symptoms initially improve on steroid therapy and he is discharged from the hospital. During the ensuing month with the tapering of the steroids, he develops new motor deficits for which he is rehospitalized. His laboratory investigation on readmission is unremarkable. However, there is significant progression of white matter lesions and microhemorrhages on repeat MRI. While in the hospital, he becomes febrile and has seizure recurrence and worsening neurologic symptoms, including cerebral salt wasting and encephalopathy. Subsequent neuroimaging demonstrates cerebral edema and diffuse brain injury. A high index of suspicion for a rare condition ultimately leads us to perform the specialized testing that confirms the diagnosis. We will discuss the diagnostic challenges that arise from an atypical presentation of an uncommon condition, and from the disease progression that is modified by previous interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 by the American Academy of Pediatrics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tlais</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatric Hematology/Oncology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fetzko</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Hematology/Oncology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulati</LastName><ForeName>Nitya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Hematology/Oncology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Huy Brandon D</ForeName><Initials>HBD</Initials><AffiliationInfo><Affiliation>Department of Radiology, Division of Pediatric Neuroradiology, Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Risen</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Neurology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Yi-Chen</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Divisions of Pediatric Critical Care Medicine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12 CA090433</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatrics</MedlineTA><NlmUniqueID>0376422</NlmUniqueID><ISSNLinking>0031-4005</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="Y">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001927" MajorTopicYN="Y">Brain Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>CONFLICT OF INTEREST DISCLAIMER:</b> The authors have indicated they have no conflicts of interest relevant to this article to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36325804</ArticleId><ArticleId IdType="mid">NIHMS1879460</ArticleId><ArticleId IdType="pmc">PMC10026691</ArticleId><ArticleId IdType="doi">10.1542/peds.2022-057652</ArticleId><ArticleId IdType="pii">189899</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cole J, Evans E, Mwangi M, Mar S. Acute disseminated encephalomyelitis in children: an updated review based on current diagnostic criteria. Pediatr Neurol. 2019;100:26&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pubmed">31371120</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton PN, Dale RC, Blyth CC, et al. Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study Clin Infect Dis. 2020;70(12):2517&#x2013;2526</Citation><ArticleIdList><ArticleId IdType="pubmed">31549170</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on Infectious Diseases AAoP. Kim-berlin DW, Barnett ED, Lynfield R, Sawyer MH. Red Book: 2021&#x2013;2024 Report of the Committee on Infectious Diseases. Itasca, IL: American Academy of Pediatrics; 2021</Citation></Reference><Reference><Citation>Horne A, Trottestam H, Aric&#xf2; M, et al. Histiocyte Society. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2008;140(3):327&#x2013;335</Citation><ArticleIdList><ArticleId IdType="pubmed">18076710</ArticleId></ArticleIdList></Reference><Reference><Citation>Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019;15(2):89&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pubmed">30559466</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann M, Hennes EM, Schanda K, et al. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases. Mult Scler. 2016;22(14):1821&#x2013;1829</Citation><ArticleIdList><ArticleId IdType="pubmed">26869530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bester M, Petracca M, Inglese M. Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases. Semin Roentgenol. 2014;49(1):76&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pubmed">24342677</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi A. Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin N Am. 2008;18(1):149&#x2013;161; ix</Citation><ArticleIdList><ArticleId IdType="pubmed">18319160</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin WO, Guo Y, Krecke KN, et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017;140(9):2415&#x2013;2425</Citation><ArticleIdList><ArticleId IdType="pubmed">29050399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W, Li XJ, Li W, Xiao L, Ji XJ, Xu Y MRI findings of central nervous system involvement in children with haemophagocytic lymphohistiocytosis: correlation with clinical biochemical tests. Clin Radiol. 2021;76(2):159.e9&#x2013;159.e17</Citation><ArticleIdList><ArticleId IdType="pubmed">33036779</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiva K, Mahlaoui N, Beaudonnet F, et al. CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology. 2012;78(15):1150&#x2013;1156</Citation><ArticleIdList><ArticleId IdType="pubmed">22422896</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein C, Kleinschmidt-DeMasters BK, Liang X, Stence N, Tuder RM, Moore BE. A review of neuropathological features of familial and adult hemophagocytic lymphohistiocytosis. J Neuropathol Exp Neurol. 2019;78(3):197&#x2013;208</Citation><ArticleIdList><ArticleId IdType="pubmed">30726926</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung TW. CNS involvement in hemophagocytic lymphohistiocytosis: CT and MR findings. Korean J Radiol. 2007;8(1):78&#x2013;81</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2626691</ArticleId><ArticleId IdType="pubmed">17277568</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz Ruano MM, Castillo M. Brain CT and MR imaging in familial hemophagocytic lymphohistiocytosis. AJR Am J Roentgenol. 1998;170(3):802</Citation><ArticleIdList><ArticleId IdType="pubmed">9490981</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10): 1261&#x2013;1267</Citation><ArticleIdList><ArticleId IdType="pubmed">23572237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobo-Calvo A, Ruiz A, Rollot F, et al. NOMADMUS, KidBioSEP, and OFSEP study groups. Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol. 2021;89(1):30&#x2013;41</Citation><ArticleIdList><ArticleId IdType="pubmed">32959427</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Chiriboga AS, Majed M, Fryer J, et al. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol. 2018;75(11):1355&#x2013;1565</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248120</ArticleId><ArticleId IdType="pubmed">30014148</ArticleId></ArticleIdList></Reference><Reference><Citation>Waak M, Malone S, Sinclair K, et al. Acute hemorrhagic leukoencephalopathy: pathological features and cerebrospinal fluid cytokine profiles. Pediatr Neurol. 2019;100:92&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">31376926</ArticleId></ArticleIdList></Reference><Reference><Citation>Yae Y, Kawano G, Yokochi T, et al. Fulminant acute disseminated encephalomyelitis in children. Brain Dev. 2019;41(4):575&#x2013;577</Citation><ArticleIdList><ArticleId IdType="pubmed">30522797</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto PS, Taipa R, Moreira B, Correia C, Melo-Pires M. Acute hemorrhagic leukoencephalitis with severe brainstem and spinal cord involvement: MRI features with neuropathological confirmation. J Magn Reson Imaging. 2011;55(4):957&#x2013;961</Citation><ArticleIdList><ArticleId IdType="pubmed">21448963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujari SS, Kulkarni RV, Ojha P, et al. Acute haemorrhagic leukoencephalitis (AHLE)&#x2014;our experience and a short review. J Neurnimmunol. 2021;361:577751</Citation><ArticleIdList><ArticleId IdType="pubmed">34739912</ArticleId></ArticleIdList></Reference><Reference><Citation>Debinski C, Goergen S, McLean C, et al. Exploring the intersection of isolated-CNS hemophagocytic lymphohistiocytosis and pediatric chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. J Child Neurol. 2021;36(11):935&#x2013;942</Citation><ArticleIdList><ArticleId IdType="pubmed">34056941</ArticleId></ArticleIdList></Reference><Reference><Citation>Henter JI, Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr. 1997;130(3):358&#x2013;365</Citation><ArticleIdList><ArticleId IdType="pubmed">9063409</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovanovic A, Kuzmanovic M, Kravljanac R, et al. Central nervous system involvement in hemophagocytic lymphohistiocytosis: a single-center experience. Pediatr Neurol. 2014;50(3):233&#x2013;237</Citation><ArticleIdList><ArticleId IdType="pubmed">24332871</ArticleId></ArticleIdList></Reference><Reference><Citation>Henter JI, Horne A, Aric&#xf3; M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124&#x2013;131</Citation><ArticleIdList><ArticleId IdType="pubmed">16937360</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan MB, Allen CE, Greenberg J, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019;66(11):e27929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340087</ArticleId><ArticleId IdType="pubmed">31339233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H, Scull BP, Goldberg BR, et al. IFN-&#x3b3; signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS. Blood Adv. 2021;5(17):3457&#x2013;3467</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525230</ArticleId><ArticleId IdType="pubmed">34461635</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson LA, Li H, Henderson LA, et al. Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. Neurol Neuroimmunol Neuroinflamm. 2019;6(3):e560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6467688</ArticleId><ArticleId IdType="pubmed">31044148</ArticleId></ArticleIdList></Reference><Reference><Citation>Blincoe A, Heeg M, Campbell PK, et al. Neuroinflammatory disease as an isolated manifestation of hemophagocytic lymphohistiocytosis. J Clin Immunol. 2020;40(6):901&#x2013;916</Citation><ArticleIdList><ArticleId IdType="pubmed">32638196</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson LA, Cron RQ. Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management. Paediatr Drugs. 2020;22(1):29&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334831</ArticleId><ArticleId IdType="pubmed">31732958</ArticleId></ArticleIdList></Reference><Reference><Citation>Algahtani H, Absi A, Bassuni W, Shirah B. Adult-onset hemophagocytic lymphohistiocytosis type 2 presenting as a demyelinating disease. Mult Scler Relat Disord. 2018;25:77&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">30053752</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng WX, Yang XY, Li JW, et al. Neurologic manifestations as initial clinical presentation of familial hemophagocytic lymphohistiocytosis type 2 due to PRFI mutation in Chinese pediatric patients. Front Genet. 2020;11:126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7064636</ArticleId><ArticleId IdType="pubmed">32194620</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Benson LA, Henderson LA, et al. Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. Blood Adv. 2019;3(4):503&#x2013;507</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6391665</ArticleId><ArticleId IdType="pubmed">30760465</ArticleId></ArticleIdList></Reference><Reference><Citation>Cincinnati Children&#x2019;s Hospital Medical Center. Hemophagocytic lymphohistiocytosis gene sequencing panel. Available at: https://www.cincinnatichildrens.org/7media/cincinnati%20childrens/home/service/d/dchi/default/familial-hemophagocytic-lymphohistiocytosis.pdf.
Accessed June 23, 2022</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>